Quest Diagnostics Inc
Change company Symbol lookup
Select an option...
DGX Quest Diagnostics Inc
COP ConocoPhillips
FBP First Bancorp
PTCT PTC Therapeutics Inc
ROKU Roku Inc
WORK Slack Technologies Inc
ARKW ARK Next Generation Internet ETF
SPOT Spotify Technology SA
GBTC Grayscale Bitcoin Trust (BTC)
ARKK ARK Innovation ETF
Go

Health Care : Health Care Providers & Services | Mid Cap Blend
Company profile

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Closing Price
$124.39
Day's Change
-0.58 (-0.46%)
Bid
--
Ask
--
B/A Size
--
Day's High
125.32
Day's Low
123.33
Volume
(Heavy Day)
Volume:
3,038,490

10-day average volume:
1,488,521
3,038,490

DGX's position in the Health Care Providers & Services industry

Industry PeersDGXGHPINCFLGTENZ

Summary

Company ProfileQuest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic...
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology...
Go to GH summary
Premier, Inc. is a healthcare improvement company. The Company is uniting an alliance of approximately 4,000 United States hospitals and health systems and approximately 175,000 other providers and...
Go to PINC summary
Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The...
Go to FLGT summary
Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company's segments include Enzo Clinical Labs, Enzo Life...
Go to ENZ summary
52-Week Change

VS. INDUSTRY
16.13%
91.11%
0.33%
394.20%
11.76%
Market Cap

VS. INDUSTRY
$17.0B
$16.0B
$4.5B
$1.7B
$127.4M
Beta

VS. INDUSTRY
1.1
--
0.2
1.9
1.0
Dividend Yield

VS. INDUSTRY
1.80%
--
2.06%
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
15.64x
--
--
34.59x
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$8.4B
$271.3M
$1.3B
$135.1M
$84.5M
Profit Margin

VS. INDUSTRY
13.31%
-64.63%
29.61%
37.82%
-24.36%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
10.15%
--
--
--
--
Revenue Growth (TTM)

VS. INDUSTRY
9.45%
47.17%
9.50%
353.21%
5.43%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.